These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 16182461)

  • 1. If 'atypical' neuroleptics did not exist, it wouldn't be necessary to invent them: perverse incentives in drug development, research, marketing and clinical practice.
    Charlton BG
    Med Hypotheses; 2005; 65(6):1005-9. PubMed ID: 16182461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic safety and efficacy concerns.
    Meyer JM
    J Clin Psychiatry; 2007; 68 Suppl 14():20-6. PubMed ID: 18284274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The medical profession and the pharmaceutical industry: when will we open our eyes?
    Breen KJ
    Med J Aust; 2004 Apr; 180(8):409-10. PubMed ID: 15089732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marketing of antipsychotic drugs targeted doctors of Medicaid patients, report says.
    Roehr B
    BMJ; 2012 Oct; 345():e6633. PubMed ID: 23033376
    [No Abstract]   [Full Text] [Related]  

  • 7. Why are doctors still prescribing neuroleptics?
    Charlton BG
    QJM; 2006 Jun; 99(6):417-20. PubMed ID: 16728441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Under the radar": nurse practitioner prescribers and pharmaceutical industry promotions.
    Ladd EC; Mahoney DF; Emani S
    Am J Manag Care; 2010 Dec; 16(12):e358-62. PubMed ID: 21291293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the need for probity when physicians interact with industry.
    Scott IA
    Intern Med J; 2006 Apr; 36(4):265-9. PubMed ID: 16640747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging science, emerging ethical issues: who should fund innate alloimmunity-suppressing drugs?
    Land WG; Gutmann T; Daar AS
    Acta Chir Belg; 2008; 108(1):73-82. PubMed ID: 18411578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
    Turner MS; Stewart DW
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atypical antipsychotic-induced weight gain].
    Godlewska BR; Olajossy-Hilkesberger L; Marmurowska-Michałowska H; Olajossy M; Landowski J
    Psychiatr Pol; 2006; 40(5):995-1007. PubMed ID: 17217241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What would the patient choose? Subjective comparison of atypical and typical neuroleptics.
    Karow A; Schnedler D; Naber D
    Pharmacopsychiatry; 2006 Mar; 39(2):47-51. PubMed ID: 16555164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sertindole: new drug. Another "atypical" neuroleptic; QT prolongation.
    Prescrire Int; 2007 Apr; 16(88):59-62. PubMed ID: 17458045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns and frequency of atypical antipsychotic prescribing in psychiatric medical centers: a cross-sectional national survey.
    Diatta T; Blazejewski S; Portier A; Lignot S; Quesnot A; Moore N; Fourrier-Réglat A
    Fundam Clin Pharmacol; 2007 Aug; 21(4):371-8. PubMed ID: 17635175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do the second-generation "atypical neuroleptics" have analgesic properties? A structured evidence-based review.
    Fishbain DA; Cutler RB; Lewis J; Cole B; Rosomoff RS; Rosomoff HL
    Pain Med; 2004 Dec; 5(4):359-65. PubMed ID: 15563321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Established and atypical neuroleptics. What the family physician should know].
    Albus M
    MMW Fortschr Med; 2001 May; 143 Suppl 2():71-4. PubMed ID: 11434264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time to nip "seeding trials" in the bud.
    Katz KA
    Arch Dermatol; 2008 Mar; 144(3):403-4. PubMed ID: 18347299
    [No Abstract]   [Full Text] [Related]  

  • 20. Typical and atypical antipsychotics--the misleading dichotomy. Results from the Working Group 'Drugs in Psychiatry' (AGATE).
    Fischer-Barnicol D; Lanquillon S; Haen E; Zofel P; Koch HJ; Dose M; Klein HE;
    Neuropsychobiology; 2008; 57(1-2):80-7. PubMed ID: 18515977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.